H.Res. 1434
Passed HouseReaffirming the preemptive authority of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and the Public Health Service Act (42 U.S.C. 201 et seq.) (including regulations thereunder) with respect to State laws that inhibit access to or use of any reproductive health product.
Latest Action
Pursuant to the provisions of H. Res. 1529, H. Res. 1434 is considered passed House.
12/21/2022 • House
Summary
This resolution affirms that there is well-established authority for the Food and Drug Administration to approve, license, and otherwise regulate reproductive health products under the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act.
The resolution also affirms that (1) such federal laws preempt (i.e., supersede conflicting state or local laws) any state or local laws that prohibit or limit access to or use of any reproductive health product, and (2) the Department of Justice has authority to enforce the preemptive effect of such federal laws by suing any state or political subdivision of a state that prohibits or limits access to or use of any reproductive health product.
Passed House • 12/21/2022
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (39)
Party Breakdown
Sponsor
Cosponsors (38)
Bill Journey
Originated in the House
Introduced
October 14, 2022
Committee Review
Floor Debate
December 21, 2022
Passed Chamber
Other Chamber
President
Enacted into Law